| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Perry Wengrofsky, Ghassan Mubarak, Ahmed Shim, Pramod Theetha Kariyanna, Adam Buzidkowski, Jacob Schwartz, Samy I McFarlan. Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review. American journal of medical case reports. vol 6. issue 8. 2020-10-01. PMID:30294673. |
delta 9-tetrahydrocannibol, the main psychoactive compound in marijuana, acts via the endocannabinoid system to elicit various cardiovascular physiological effects, and has been associated with many adverse cardiovascular effects such as acute coronary syndrome, arrhythmias, and sudden cardiac death that have previously been reported by our group and others. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hasan O Keles, Milena Radoman, Gladys N Pachas, A Eden Evins, Jodi M Gilma. Using Functional Near-Infrared Spectroscopy to Measure Effects of Delta 9-Tetrahydrocannabinol on Prefrontal Activity and Working Memory in Cannabis Users. Frontiers in human neuroscience. vol 11. 2020-09-30. PMID:29066964. |
using functional near-infrared spectroscopy to measure effects of delta 9-tetrahydrocannabinol on prefrontal activity and working memory in cannabis users. |
2020-09-30 |
2023-08-13 |
human |
| Huiyan Jin, Sharifa Z Williams, Stanford T Chihuri, Guohua Li, Qixuan Che. Validity of oral fluid test for Delta-9-tetrahydrocannabinol in drivers using the 2013 National Roadside Survey Data. Injury epidemiology. vol 5. issue 1. 2020-09-30. PMID:29457201. |
delta 9-tetrahydrocannabinol (thc) is the main active compound in marijuana. |
2020-09-30 |
2023-08-13 |
Not clear |
| Vadim Yuferov, Eduardo R Butelman, Mary Jeanne Kree. Gender-specific association of functional Neuropsychiatric disease and treatment. vol 14. 2020-09-30. PMID:29713172. |
the main active component of cannabis is delta 9-tetrahydrocannabinol (delta 9-thc), a partial agonist of the cannabinoid type 1 receptor. |
2020-09-30 |
2023-08-13 |
Not clear |
| Claudio Imperatori, Chiara Massullo, Giuseppe Alessio Carbone, Angelo Panno, Marta Giacchini, Cristina Capriotti, Elisa Lucarini, Benedetta Ramella Zampa, Eric Murillo-Rodríguez, Sérgio Machado, Benedetto Farin. Increased Resting State Triple Network Functional Connectivity in Undergraduate Problematic Cannabis Users: A Preliminary EEG Coherence Study. Brain sciences. vol 10. issue 3. 2020-09-28. PMID:32121183. |
the strength of delta connectivity between the sn and cen was positively and significantly correlated with higher problematic patterns of cannabis use after controlling for age, sex, educational level, tobacco use, problematic alcohol use, and general psychopathology ( |
2020-09-28 |
2023-08-13 |
human |
| T.H. Kelly, R.W. Foltin, M.W. Fischma. Effects of smoked marijuana on heart rate, drug ratings and task performance by humans. Behavioural pharmacology. vol 4. issue 2. 2019-11-20. PMID:11224183. |
six subjects, reporting marijuana use between two and 30 times per month, participated in studies of the acute effects of smoked marijuana (0.0%, 2.0% and 3.5% delta(9)-thc, w/w) on heart rate, ratings of drug effect and task performance. |
2019-11-20 |
2023-08-12 |
human |
| Luca Zamengo, Chiara Bettin, Denis Badocco, Valerio Di Marco, Giorgia Miolo, Giampietro Friso. The role of time and storage conditions on the composition of hashish and marijuana samples: A four-year study. Forensic science international. vol 298. 2019-11-20. PMID:30901710. |
six high-potency cannabis products constituted by herbal and resin materials containing different initial concentrations of delta 9-tetrahydrocannabinol (thc) were employed for this study. |
2019-11-20 |
2023-08-13 |
Not clear |
| Shikha Prashad, Elizabeth S Dedrick, Francesca M Filbe. Cannabis users exhibit increased cortical activation during resting state compared to non-users. NeuroImage. vol 179. 2019-02-13. PMID:29894828. |
cannabis users exhibited decreased delta and increased theta, beta, and gamma power compared to controls, suggesting increased cortical activation in resting state and a disinhibition of inhibitory functions that may interrupt cognitive processes. |
2019-02-13 |
2023-08-13 |
Not clear |
| Hannah M Jensen, Rozalia Korbut, Per W Kania, Kurt Buchman. Cannabidiol effects on behaviour and immune gene expression in zebrafish (Danio rerio). PloS one. vol 13. issue 7. 2019-01-07. PMID:30063756. |
one of the dominating cannabis constituents, delta(9)-tetrahydrocannabinol (thc), has previously been studied in depth whereas information on another main ingredient cannabidiol (cbd) is limited. |
2019-01-07 |
2023-08-13 |
zebrafish |
| Maria C Rotolo, Silvia Graziano, Manuela Pellegrini, Daniele Corlazzoli, Lucia Antinori, Laura Porcarelli, Simona Pichin. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy. Current pharmaceutical biotechnology. vol 18. issue 10. 2018-05-29. PMID:29173160. |
simple and fast gas-chromatography mass spectrometry assay to assess delta 9-tetrahydrocannabinol and cannabidiol in dogs treated with medical cannabis for canine epilepsy. |
2018-05-29 |
2023-08-13 |
dog |
| Maria C Rotolo, Silvia Graziano, Manuela Pellegrini, Daniele Corlazzoli, Lucia Antinori, Laura Porcarelli, Simona Pichin. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy. Current pharmaceutical biotechnology. vol 18. issue 10. 2018-05-29. PMID:29173160. |
to date, an increasing number of pet owners, especially in the usa, are using cannabis-derived products containing generally delta 9-tetrahydrocannabinol (thc) and cannabidiol (cbd) to help their animals' health. |
2018-05-29 |
2023-08-13 |
dog |
| Francesco P Busardò, Manuela Pellegrini, Julia Klein, Natale M di Luc. Neurocognitive Correlates in Driving Under the Influence of Cannabis. CNS & neurological disorders drug targets. vol 16. issue 5. 2018-05-01. PMID:28440193. |
delta (9)-tetrahydrocannabinol (thc) is the main psychoactive compound in cannabis and is frequently identified in blood samples from apprehended drivers suspected for driving under the influence of drugs. |
2018-05-01 |
2023-08-13 |
Not clear |
| Melissa E Badowsk. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer chemotherapy and pharmacology. vol 80. issue 3. 2017-12-27. PMID:28780725. |
oral cannabinoids (i.e., dronabinol, nabilone) containing the active component of marijuana, delta(Δ)9-tetrahydrocannabinol (thc), are available for the treatment of chemotherapy-induced nausea and vomiting (cinv) in patients with cancer who have failed to adequately respond to conventional antiemetic therapy. |
2017-12-27 |
2023-08-13 |
Not clear |
| Barth Wilsey, Thomas D Marcotte, Reena Deutsch, Holly Zhao, Hannah Prasad, Amy Pha. An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. The journal of pain. vol 17. issue 9. 2017-09-19. PMID:27286745. |
after obtaining baseline data, 42 participants underwent a standardized procedure for inhaling 4 puffs of vaporized cannabis containing either placebo, 2.9%, or 6.7% delta 9-thc on 3 separate occasions. |
2017-09-19 |
2023-08-13 |
human |
| Dursun Fırat Ergül, Serdar Ekemen, Birgül Büyükkıdan Yelke. Synthetic Cannabinoid 'Bonzai' Intoxication: Six Case Series. Turkish journal of anaesthesiology and reanimation. vol 43. issue 5. 2016-07-01. PMID:27366526. |
it has structurally similar chemical characteristics as delta 9-tetrahydrocannabinol (thc), the active substance in marijuana. |
2016-07-01 |
2023-08-13 |
Not clear |
| C J Fowle. Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25669486. |
delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: a critical examination of the preclinical literature. |
2015-08-12 |
2023-08-13 |
Not clear |
| C J Fowle. Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25669486. |
but do delta(9) -tetrahydrocannabinol (Δ(9) -thc) and cannabidiol (cbd) cure cancer? |
2015-08-12 |
2023-08-13 |
Not clear |
| Ziva D Cooper, Richard W Foltin, Carl L Hart, Suzanne K Vosburg, Sandra D Comer, Margaret Hane. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addiction biology. vol 18. issue 6. 2014-08-04. PMID:22741619. |
on the first in-patient day, active marijuana [6.2% delta (9)-tetrahydrocannabinol (thc)] was repeatedly smoked under controlled conditions. |
2014-08-04 |
2023-08-12 |
human |
| Epaenetus A Awuzu, Emmanuel Kaye, Patrick Vudrik. Prevalence of cannabis residues in psychiatric patients: a case study of two mental health referral hospitals in Uganda. Substance abuse : research and treatment. vol 8. 2014-01-23. PMID:24453492. |
the aims of this study were to determine the prevalence of delta 9-tetrahydrocanabinol (Δ(9)-thc), a major metabolite of cannabis, in psychiatric patients in uganda, and to assess the diagnostic capacity of two referral mental health hospitals to screen patients for exposure to cannabis in uganda. |
2014-01-23 |
2023-08-12 |
Not clear |
| Priyamvada Sharma, Pratima Murthy, M M Srinivas Bharat. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iranian journal of psychiatry. vol 7. issue 4. 2013-02-15. PMID:23408483. |
the primary psychoactive constituent of cannabis, delta 9-tetrahydrocannabinol (▵(9_)thc), produces a myriad of pharmacological effects in animals and humans. |
2013-02-15 |
2023-08-12 |
human |